Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting
2015 · mAbs · 51 citations
https://doi.org/10.1080/19420862.2015.1106658
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
26
Papers
669
Citations
14
h-index
14
i10-index
Saskia Meyer is an academic researcher from Oslo University Hospital. The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & Glycosylation and Glycoproteins Research & T-cell and B-cell Immunology. The author has an h-index of 14, co-authored 23 publications.
https://doi.org/10.1080/19420862.2015.1106658
https://doi.org/10.1158/2326-6066.cir-15-0099-t
https://doi.org/10.1016/j.celrep.2023.111995
Click to start Chat